Lenz Therapeutics, Inc. · NASDAQ:LENZ
BlackRock, Inc. reported a 5.80% stake in Lenz Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc. reported a 5.80% stake in Lenz Therapeutics, Inc., 1,804,099 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 1,804,099
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 1,804,099 |
Source
Related
- Lenz Therapeutics, Inc.
- BlackRock, Inc.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026